
An advisory panel of the U.S.Centers for Disease Control and Prevention voted on Wednesday to recommend the first RSV vaccines for seniors. The U.S. Food and Drug Administration has already approved the vaccines, one made by GSK called Arexvy and a version from Pfizer Inc. called Abrysvo. During the meeting, the panel called for “shared… read on > read on >